Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.47 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.47 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.43 |
| ▸ | MMP1 | P03956 | 1/20 | 0.43 |
| ▸ | MMP3 | P08254 | 1/20 | 0.43 |
| ▸ | MMP7 | P09237 | 1/20 | 0.43 |
| ▸ | MMP13 | P45452 | 1/20 | 0.43 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | BDKRB1 | P46663 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL492515 | 0.84 | RAB9A (0.49) | RAB9ANPC1FKBP1AMMP1MMP3 | |
| SCHEMBL3797432 | 0.81 | RAB9A (0.49) | RAB9ANPC1FKBP1AMMP1MMP3 | |
| SCHEMBL3408435 | 0.79 | RAB9A (0.47) | RAB9ANPC1FKBP1AMMP1MMP3 | |
| SCHEMBL493175 | 0.79 | RAB9A (0.58) | RAB9ANPC1FKBP1AMMP1MMP3 | |
| SCHEMBL492819 | 0.78 | ALDH1A1 (0.47) | RAB9ANPC1MMP1MMP3MMP7 | |
| SCHEMBL492750 | 0.78 | NPC1 (0.52) | RAB9ANPC1MMP1MMP3MMP7 | |
| SCHEMBL492935 | 0.77 | NPC1 (0.46) | RAB9ANPC1MMP1MMP3MMP7 | |
| SCHEMBL3413278 | 0.77 | RAB9A (0.43) | RAB9ANPC1FKBP1AMMP1MMP3 | |
| SCHEMBL493720 | 0.76 | RAB9A (0.46) | RAB9ANPC1FKBP1AMMP1MMP3 | |
| SCHEMBL492986 | 0.75 | RAB9A (0.49) | RAB9ANPC1FKBP1AMMP1MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090253669-A1 | Substituted Sulfonamide Compounds | GRUENENTHAL GMBH (DE) | 2009-10-08 | — | — | US | claimed |
| US-20090253669-A1 | Substituted Sulfonamide Compounds | GRUENENTHAL GMBH (DE) | 2009-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090253669-A1 | Substituted Sulfonamide Compounds | SULT2A1, STS, SULT1A1 | RAB9A 2485/4885NPC1 2399/4885OPRM1 2798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.